Palpitations in Young People: 2 ECG Challenges
Palpitations and syncope during dinner (him); arrhythmia that looks like SVT after 2 energy drinks (her). What do the ECGs tell you?
US Adolescent E-cigarette Users at Increased Risk for COVID-19
A new survey found adolescents who have ever used e-cigarettes are 5-times more likely to receive a COVID-19 diagnosis. More results at-a-glance in our new slideshow.
Marijuana Risks and Benefits: What do US Adults Believe?
The perception of marijuana's risks and benefits may be changing within the US adult population. Are you up to date?
Beyond Boomers: CDC Urges HCV Screening for All US Adults
HCV is now diagnosed in millennials at about the same rate as in baby boomers; CDC responds with a recommendation for HCV screening in all adults aged ≥18 years.
Immunization During COVID-19: CDC Vaccination Guidance for Clinicians
Communicating the importance of immunization to wary patients is key during the COVID-19 pandemic. Check out our new slideshow for the most recent CDC guidance for clinicians.
MD vs Machine: 2 ECG Challenges
Computer-interpreted ECGs are part of SOP -- but the interpretation still needs confirmatin. See if your ECG read matches the machine in 2 cases from the ED.
NIH Names 7 Companies for COVID-19 Testing Scaleup
NIH "shark tank" week yields 7 COVID-19 diagnostic testing companies now awarded $2.5 million to scale up rapid lab and point-of-care testing.
8 Questions on Behçet Diagnosis in Primary Care
Primary care physicians are in a prime position to recognize BD—if you know what to look for. Take this brief quiz to find out what you know.
Behçet Disease Treatment Basics for Primary Care
For patients with Behcet disease, primary care practitioners play a key role in coordinating and monitoring care that requires multiple medications and doctors.
NIH Updates COVID-19 Treatment Guidance on Corticosteroids, Advance Planning
The National Institutes of Health updated guidance on use of dexamethasone and substitutes in critically ill patients, and on ensuring surrogate decision makers are identified.
US Vaccination Rates Ranked by State: 5 Highest, 5 Lowest in 8 Categories
Flu vaccination coverage for adults is highest in West Virginia, lowest in Louisiana. Where does your state rank on flu, HPV, pneumococcal and 5 other vaccines?
5 Questions on How to Manage Hypertension in Primary Care
Hypertension is the modifiable cardiovascular disease risk factor responsible for the greatest mortality. Test what you know about management.
COVID-19 Surge Meets Flu Season (plus Other Primary Care Concerns)
The summer surge in COVID-19 cases has primary care clinicians caught between re-opening safely, addressing rebound care, and planning for flu season.
Lipid Management to Reduce ASCVD Risk: What Would AHA/ACC Do?
Try these 5 questions on patient CVD risk scenarios likely to present to primary care. Find out what you know about AHA/ACC guideline-recommended strategies.
FDA Alert: Hand Sanitizer Methanol Contamination
Hand sanitizer products contaminated with methyl alcohol have caused serious adverse events, including hospitalization, blindness, and death.
Medicare Use of Telehealth During COVID-19
Medicare beneficiary use of telehealth services reached nearly 9 million as COVID-19 shut down on-site visits. Will the options be permanent?
AHA Guidelines on Obesity for CVD Prevention: 5 Questions
Obesity is a primary risk factor for cardiovascular disease and can also be modified with comprehensive care. Test yourself on the AHA/ACC recommendations for that care.
COVID-19 Health Improvements: State by State
A new survey examined which states have experienced a positive or negative trend in their residents’ health in recent weeks of the pandemic. Find out which states are recovering in our quick slideshow.
8 New Drugs for Primary Care: Q2 2020
The first and only non-hormonal gel for pregnancy prevention, the first minocycline product for use in rosacea, and 6 more recently approved drugs of interest to primary care.
SGLT2 Inhibitors & GLP-1 Receptor Agonists: Differences, Similarities, Patient Selection
SGLT2 inhibitors and GLP-1 receptor agonists are changing the type 2 diabetes treatment paradigm. We summarize the most recent data here and offer guidance on patient benefits.